rxstat › Shortages › Olopatadine
Olopatadine shortage status
Partial shortage
Source: Health Canada shortage reports · Updated Jul 9, 2026
Some Olopatadine products are in shortage in Canada (5 of 11 reported products), while others remain available. Your pharmacy may be able to substitute an unaffected manufacturer. The latest estimate for affected products to return is Mar 31, 2026.
In shortage since
Sep 1, 2018
Est. full return
Mar 31, 2026
Talk to your pharmacist. Pharmacists can often substitute another manufacturer's version, a different strength, or (in most provinces) adapt or renew a prescription on the spot. Your free provincial health line is 811.
Reports by product
Active shortageJAMP-OLOPATADINE
0.1% · SOLUTION · JAMP PHARMA CORPORATION
DIN 02458411 · since Aug 7, 2025, est. end Mar 31, 2026 · Disruption of the manufacture of the drug.
Active shortageAPO-OLOPATADINE
0.2% · SOLUTION · APOTEX INC
DIN 02402823 · since Mar 26, 2024, no end estimate · Disruption of the manufacture of the drug.
Active shortageAPO-OLOPATADINE
0.1% · SOLUTION · APOTEX INC
DIN 02305054 · since Jun 1, 2020, no end estimate · Disruption of the manufacture of the drug.
Active shortageACT OLOPATADINE 0.1%
0.1% · SOLUTION · ACTAVIS PHARMA COMPANY
DIN 02403986 · since Sep 1, 2018, no end estimate · Disruption of the manufacture of the drug.
Active shortageACT OLOPATADINE 0.2%
0.2% · SOLUTION · ACTAVIS PHARMA COMPANY
DIN 02404095 · since Sep 1, 2018, no end estimate · Disruption of the manufacture of the drug.
ResolvedOLOPATADINE 0.2%
0.2% · SOLUTION · SANIS HEALTH INC
DIN 02541653 · ended Dec 10, 2025 · Disruption of the manufacture of the drug.
ResolvedOLOPATADINE 0.2%
0.2% · SOLUTION · SANIS HEALTH INC
DIN 02541653 · ended Nov 7, 2025 · Disruption of the manufacture of the drug.
ResolvedSANDOZ OLOPATADINE 0.2%
0.2% · SOLUTION · SANDOZ CANADA INCORPORATED
DIN 02420171 · ended Oct 31, 2025 · Disruption of the manufacture of the drug.
ResolvedPATADAY
0.2% · SOLUTION · NOVARTIS PHARMACEUTICALS CANADA INC
DIN 02362171 · ended Oct 10, 2025 · Demand increase for the drug.
ResolvedSANDOZ OLOPATADINE 0.2%
0.2% · SOLUTION · SANDOZ CANADA INCORPORATED
DIN 02420171 · ended Aug 4, 2025 · Disruption of the manufacture of the drug.
ResolvedJAMP-OLOPATADINE
0.1% · SOLUTION · JAMP PHARMA CORPORATION
DIN 02458411 · ended Jul 31, 2025 · Other (Please describe in comments)
ResolvedSANDOZ OLOPATADINE 0.2%
0.2% · SOLUTION · SANDOZ CANADA INCORPORATED
DIN 02420171 · ended May 19, 2025 · Disruption of the manufacture of the drug.
Showing 12 of 32 reports. All reports are on file with Health Canada.
What's happening
Olopatadine is currently affected by 5 active shortage reports filed with Health Canada by JAMP PHARMA CORPORATION, APOTEX INC, ACTAVIS PHARMA COMPANY.
The reported cause is: disruption of the manufacture of the drug. Manufacturers must report shortages, but end-date estimates are their own projections and often move.
If your usual product is affected, a pharmacist is the fastest route to a solution: they can dispense an unaffected manufacturer's equivalent when one exists, and in most provinces can adapt doses or substitute a therapeutic alternative without a new appointment.
Olopatadine is classified under “DECONGESTANTS AND ANTIALLERGICS” (ATC S01GX).
Recent changes
Common questions
When will Olopatadine be back in stock in Canada?
The latest manufacturer estimate is Mar 31, 2026. Estimates are self-reported and often slip; this page updates automatically when they change.
Why is Olopatadine in shortage?
See the reports above; manufacturers must state a reason (most commonly manufacturing disruption or a surge in demand) when filing with Health Canada.
What can my pharmacist do about it?
Often quite a lot: substitute an equivalent product from an unaffected manufacturer, adjust quantities, or in most provinces adapt or renew prescriptions on the spot. Call your pharmacy before visiting, and call 811 for free health advice.
Guides: what to do when your medication is in shortage · how to read shortage reports
Data reflects reports manufacturers are legally required to file with Health Canada, republished with per-drug aggregation by rxstat. Estimated end dates are supplied by manufacturers and frequently change. This page describes drug supply only and is not medical advice; never stop or switch a medication without speaking to your pharmacist or prescriber.